BioSpace News Archive

- A simple blood test for Alzheimer’s would be a great advance for individuals with — and at risk for — the disease, families, doctors and researchers. At the Alzheimer’s Association International Conference

American Gene Technologies (AGT), an internationally recognized leading gene and cell therapy company in Rockville, Maryland, today announced it has leased a spacious, modern facility in the Maryland life sciences corridor, across from National Cancer Institute and Johns Hopkins Shady Grove Campus.

A new survey of U.S. clinical laboratories conducted by AACC has found that nearly half of all responding labs still do not have the supplies they need to run COVID-19 tests.

A peer-reviewed research article published today in the Journal of Experimental Medicine, titled “Blood plasma phosphorylated-tau isoforms track CNS [central nervous system] change in Alzheimer’s disease,” finds that the brain protein tau phosphorylated at position 217 (p-tau217) is measurable in blood by mass spectrometry and that this form of tau is a powerful early indicator of Alzheimer’s disease.

Life sciences professionals are confident in their job security despite the economy, according to a new survey by global recruiter EPM Scientific.

Neocis, Inc., the leader and pioneer in robot-assisted dental implant surgery, announced today that they have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new Yomi® edentulous indication. The clearance allows for a new splint attachment which broadens Yomi’s application to include full arch implant cases as well as partially edentulous cases. The American College of Prosthodontists estimates that over 36 million Ameri

TearLab Corporation (TearLab), an eye care medical device firm marketing lab-on-a-chip diagnostic technologies at the point-of-care, today announced the appointment of Adam Szaronos to the position of Chief Commercial Officer (CCO).

Valeo Pharma Inc. (CSE: VPH) (“Valeo” or the “Company”), a Canadian specialty pharmaceutical company, announced today that it will be presenting at Wall Street Reporter’s livestream conference on Wednesday July 29, 2020.

Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter financial results and provide a corporate update on August 4, 2020.

Amgen (NASDAQ:AMGN) today announced financial results for the second quarter of 2020.